Study details
Enrolling now
Endotypic Traits and Obstructive Sleep Apnea Surgery
University of California, Los Angeles
NCT IDNCT05953610ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
150
Study length
about 4.7 years
Ages
21+
Locations
2 sites in CA
What this study is about
Researchers are testing factors that affect how well people do after surgery for obstructive sleep apnea. The trial also looks at medications (acetazolamide, eszopiclone) to see if they can help treat other causes of the condition like increased arousal or changes in breathing patterns.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Acetazolamide 500 MG QHS
- 2.Take Eszopiclone 3 mg QHS
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
OralOral
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
NERVOUS SYSTEM
Drug routes
oral (Oral Tablet)